Healthy Women Image

Barb DePree, MD, NCMP,MMM

Director of the Women's Midlife Services at Holland Hospital

Holland, MI

Dr. Barb DePree, a gynecologist in practice for over 30 years, specializes in midlife women's health. She is certified through the North American Menopause Society as a provider, and was named the 2013 NAMS Certified Menopause Provider of the year. Dr. DePree currently serves as the director of the Women’s Midlife Services at Holland Hospital, Holland, Michigan. In 2018, she completed a certification in Genetic Cancer Risk Assessment.

A member of NAMS, ACOG and ISSWSH, Dr. DePree has been a presenter for the ACOG CME audio program. She has served as a key opinion leader for Shionogi, AMAG, Duchesnay, Valeant, Wyeth and Astellas leading physician education, and participating in research projects and advisory panels.

Finding that products helpful to her patients’ sexual health were not readily available, Dr. DePree founded MiddlesexMD.com that shares practice-tested, clinically sound information and products, including guidance for working with partners and caregivers. Dr. DePree publishes regularly on her own blog, providing updates on research in women’s sexual health, as well as observations and advice based on her work with women in her practice. Sharecare named her as a Top 10 Social Healthmaker for Menopause in September of 2013. In 2017, she was named among the “Top 10 Best Menopause Blogs” by Medical News Today. Dr. DePree also publishes podcast interviews on women in midlife, exploring the ways they have made the transition in their lives and careers.

Full Bio
Avoid Pellets When Using Testosterone for Low Libido

Avoid Pellets When Using Testosterone for Low Libido

Although testosterone treatments for women aren't FDA-approved, some forms have shown success. But pelletized testosterone is harder to manage.

Your Health

Q. Would you recommend pelletized subcutaneous testosterone?

A. You say you're considering pelletized subcutaneous testosterone as a response to flagging libido. I have seen good results with testosterone therapy, which you can read about in this blog post.

Testosterone, however, is one time that I never recommend pellets. It's very difficult to manage levels and dosing in the pellet form, and I've seen plenty of awful outcomes of way-too-high doses, including masculinization that in some cases is irreversible (clitoral enlargement is one possible irreversible consequence, for instance).

While testosterone treatments are not FDA-approved for women in the U.S., we have plenty of data on transdermal, bioidentical testosterone use in women, and I think there is evidence those can be used safely if kept in female therapeutic ranges. I just don't see pellets as allowing management in that safe therapeutic range. I use male pharmaceutical products at a fraction of the dose used for men.

Estrogen is fine in pellet form, but even there I rarely use pellets. We have such great bioidentical pharmaceutical products that are so much easier and flexible to use, with known, consistent dosing, which pellets just can't provide. It's hard to get too much estrogen delivered to women, in general. Although I have seen super-high levels with pellets, we don't have information that this is harmful, and the only adverse side effect is usually breast soreness, which is reversible.

Barb DePree, MD, has been a gynecologist for 30 years, specializing in menopause care for the past 10. Dr. DePree was named the Certified Menopause Practitioner of the Year in 2013 by the North American Menopause Society. The award particularly recognized the outreach, communication and education she does through MiddlesexMD, a website she founded and where this blog first appeared. She also is director of the Women's Midlife Services at Holland Hospital, Holland, Michigan.

You might be interested in